EFDID: 565293EFD: View Filing

Issuer: Amalgam Rx, Inc. (0001667234) - D

Accession: 0001667234-25-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001667234
  • Entity Name:
    Amalgam Rx, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    206 ALAPOCAS DRIVE
    WILMINGTON, DE 19803
  • Persons:
    Related Persons 3
    RYAN A. SYSKO
    Executive Officer, Director
    JEFFREY P. COURTNEY
    Director
    SONNY VU
    Director
EDGAR: Offering Information
  • Accession Date:
    08/15/2025
  • First Sale Date:
    08/08/2025
  • Offering Amount:
    $7,886,530
  • Amount Sold:
    $7,886,530
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Debt
  • Sales Clarification:
    A portion of the offering amount represents loan proceeds, which are convertible into equity securities of the issuer pursuant to the terms and conditions of a loan and security agreement.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, DE, GA, IN, MD, NJ, NY, VA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
ERG SECURITIES (US) LLC 121057 None None NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Amalgam Rx, Inc./s/ Ryan A. SyskoRyan A. SyskoChief Executive Officer2025-08-15